眼科疾病之治療
- 专利权人:
- F. HOFFMANN-LA ROCHE AG;GENENTECH, INC.
- 发明人:
- WEIKERT, ROBERT JAMES,威克特 罗柏特 詹姆士,威克特 羅柏特 詹姆士,OSBORNE, AARON,奥斯本 亚伦,奧斯本 亞倫,SAHNI, JAYASHREE,沙尼 嘉亚许瑞,沙尼 嘉亞許瑞
- 申请号:
- TW108104518
- 公开号:
- TW202000700A
- 申请日:
- 2019.02.11
- 申请国别(地区):
- TW
- 年份:
- 2020
- 代理人:
- 摘要:
- The current invention relates to the use of antibodies which bind to VEGF and ANG2 for the treatment of ophthalmologic diseases.本發明係關於結合至VEGF及ANG2之抗體用於治療眼科疾病之用途。
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- Treatment of ophthalmologic diseases
- TREATMENT OF OPHTHALMOLOGIC DISEASES
- TRAITEMENT DE MALADIES OPHTHALMOLOGIQUES
- Antibodies that bind to canine vascular endothelial growth factor and their use in the treatment of canine angiogenesis-related diseases
- Antibodies which specifically bind to canine vascular endothelial growth factor and uses thereof